Analysts' Updated EPS Estimates for May 17th (ACSO, ALBO, ALT, BEZ, CAML, CCR, CGEM, EGLX, ETSY, FNLPF)
Analysts’ updated eps estimates for Tuesday, May 17th: accesso Technology Group (LON:ACSO) had its buy rating reissued by analysts at Shore Capital. Albireo Pharma (NASDAQ:ALBO) had its buy rating reaffirmed by analysts at Wedbush. The firm currently has a $72.00 target price on the stock. Altimmune (NASDAQ:ALT) had its buy rating reaffirmed by analysts at […]